ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BOOM DMC Global Inc

14.89
0.15 (1.02%)
After Hours
Last Updated: 22:07:11
Delayed by 15 minutes
Share Name Share Symbol Market Type
DMC Global Inc NASDAQ:BOOM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 1.02% 14.89 14.74 15.10 15.07 14.75 14.84 231,398 22:07:11

Lifshitz & Miller Law Firm Announces Investigation of Accelerate Diagnostics, Inc., Adamis Pharmaceuticals Corporation, Aeroh...

03/04/2015 11:47pm

PR Newswire (US)


DMC Global (NASDAQ:BOOM)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more DMC Global Charts.

NEW YORK, April 3, 2015 /PRNewswire/ --

Accelerate Diagnostics, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of Accelerate Diagnostics, Inc. (AXDX).  Specifically, on February 18, 2015, Seeking Alpha reported that AXDX falsely claimed that it had developed a technique for diagnosing pathogens in a blood sample without a need for using a blood culture.  In reality, the test required a blood culture.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Adamis Pharmaceuticals Corporation

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of Adamis Pharmaceuticals Corporation (ADMP).  Specifically, on March 27, 2015, the Company announced that it received a CRL from the FDA regarding its NDA Epinephrine Injection USP 1:1000 0.3mg Pre-filled Single Dose Syringe (PFS) product, for the emergency treatment of acute anaphylaxis, which is a severe allergic reaction.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Aerohive Networks, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of Aerohive Networks, Inc. (HIVE).  Specifically, on October 13, 2014, following the March 28, 2014 IPO, HIVE lowered third quarter revenue forecasts and increased loss forecasts.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Boulder Brands, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of Boulder Brands, Inc. (BDBD).  Specifically, on October 22, 2014, the Company announced "…we faced a number of headwinds that impacted our financial results," and that it was "expecting lower shipments due to a normalizing of certain inventories at our largest customer."

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Dynamic Materials Corporation

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of Dynamic Materials Corporation (BOOM).  Specifically, on March 6, 2015, BOOM announced, it "incorrectly accounted for income tax expense and related deferred tax assets and liabilities at its business entities in Germany."  As a result, it was determined a restatement of the related consolidated financial statements and a reevaluation of internal controls was necessary.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

SanDisk Corp.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of SanDisk Corp. (SNDK).  Specifically, on March 26, 2015, SNDK lowered first quarter revenue forecast to $1.3 billion, from guidance of $1.4 billion to $1.45 billion.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2015 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-accelerate-diagnostics-inc-adamis-pharmaceuticals-corporation-aerohive-networks-inc-boulder-brands-inc-dynamic-materials-corporation-and-sandisk-corp-300060980.html

SOURCE Lifshitz & Miller Law Firm

Copyright 2015 PR Newswire

1 Year DMC Global Chart

1 Year DMC Global Chart

1 Month DMC Global Chart

1 Month DMC Global Chart